Long-term course of reflux symptoms following Helicobacter pylori eradication;Langzeitverlauf von refluxbeschwerden nach helicobacter pylori-eradikation

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 13, 2004, Pages 671-675

  Peitz, U ^a   Raps, S ^b   Plein, K ^b   Leodolter, A ^a   Hotz, J ^b   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b ALLGEMEINES KRANKENHAUS CELLE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; OMEPRAZOLE; UREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; STOMACH BIOPSY; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; ESOPHAGITIS, PEPTIC; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OMEPRAZOLE; PEPTIC ULCER; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 1842432002     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820578     Document Type: Article

References (36)

1. Anonymous. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44 (Suppl 2); S1-16
2. Befrits R, Sjostedt S, Odman B, Sorngard H, Lindberg G. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 2000; 5: 202-205
3. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 179: 1523-1530
4. Blum AL, Talley NJ, O'Morain C et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339: 1875-1881
5. Calam J, Gibbons A, Healey ZV, Bliss P, Arebi N. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 1997; 113: S43-S49
6. Caspary WF, Rösch W. Diagnostik und Therapie der Helicobacter-pylori-Infektion bei Erwachsenen. Dtsch Med Wochenschr 1996; 121: 1375-1378
7. Chow WH, Blaser MJ, Blot WJ et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588-590
8. El Omar EM, Oien K, El Nujumi A et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24
9. El Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-333
10. El Serag HB, Sonnenberg A, Jamal MM et al. Corpus gastritis is protective against reflux oesophagitis. Gut 1999; 45: 181-185
11. Fallone CA, Barkun AN, Friedman G et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: 914-920
12. Gutierrez O, Melo M, Segura AM et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 664-668
13. Koike T, Ohara S, Sekine H et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001; 15: 813-820
14. Koskenpato J, Farkkila M, Sipponen P. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Scand J Gastroenterol 2002; 37: 778-784
15. Labenz J, Blum AL, Bayerdörffer E et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447
16. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002; 97: 2992-2997
17. 13C-urea breath test for pre- and post-treatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol 1999; 94: 2100-2104
18. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002; 16: 167-180
19. Malfertheiner P, Peitz U. Einfluss von H. pylori auf GERD und Barrett-Ösophagus. Bremen: UNI-MED, In: Pohl T, Domschke W, Herausgeber. Gastroösophageale Refluxkrankheit (GERD) - Barrett-Ösophagus. 2002: 36-47
20. Malfertheiner P, Dent J, Zeijlon L et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programme. Aliment Pharmacol Ther 2002; 16: 1431-1442
21. Malfertheiner P, Enrique Dominguez-Munoz J, Heckenmüller H et al. Modified rapid urease test for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996; 8: 53-56
22. Malfertheiner P, Holtmann G, Peitz U et al. Leitlinien der Deutschen Gesellschaft fur Verdauungs- und Stoffwechselkrankheiten zur Behandlung der Dyspepsie. Z Gastroenterol 2001; 39: 937-956
23. McNamara D, Buckley M, O'Morain C. Helicobacter pylori-induced duodenal ulcer frequently coincides with gastro-oesophageal reflux disease. Dig Liver Dis 2002; 34: 542-546
24. Meining A, Stolte M, Hatz R et al. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997; 431: 11-15
25. Miehlke S, Hackelsberger A, Meining A et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998; 78: 263-266
26. Moayyedi P, Bardhan C, Young L et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001; 121: 1120-1126
27. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003; CD002096
28. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: 737
29. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895
30. Schwizer W, Thumshirn M, Dent J et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001; 357: 1738-1742
31. Talley NJ, Stanghellini V, Heading RC et al. Functional gastroduodenal disorders. Gut 1999; 45: II37-II42(Suppl 2
32. Vaezi MF, Falk GW, Peek RM et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000; 95: 2206-2211
33. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 45-51
34. Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-57
35. Weston AP, Badr AS, Topalovski M et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-394
36. Wu AH, Crabtree JE, Bernstein L et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-821